• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索S100A9在溃疡性结肠炎及其癌变过程中的临床意义:从炎症到癌症的历程

Exploring the Clinical Implication of S100A9 in Ulcerative Colitis and Its Progression to Cancer: A Journey from Inflammation to Cancer.

作者信息

Cheon Jaehwan, Kim Sang Hyun, Park Jaehyung, Kim Tae Hoon

机构信息

Department of Otorhinolaryngology-Head & Neck Surgery, Korea University College of Medicine, Anam-ro 145, Seongbuk-gu, Seoul 02841, Republic of Korea.

Department of Biomedical Science, Korea University College of Medicine, Anam-ro 145, Seongbuk-gu, Seoul 02841, Republic of Korea.

出版信息

Int J Mol Sci. 2025 Jun 13;26(12):5693. doi: 10.3390/ijms26125693.

DOI:10.3390/ijms26125693
PMID:40565156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192605/
Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation and debilitating symptoms that considerably impair life quality. UC is particularly prevalent in younger populations, where early diagnosis remains challenging owing to nonspecific symptoms and the potential progression to colitis-associated cancer (CAC). The GSE177044 dataset, consisting of whole blood samples, was analyzed to identify differentially expressed genes, perform gene annotation, analyze key signaling pathways, and detect key hub genes in UC using protein-protein interaction networks. Multiple UC datasets composed of colonic samples were used for validation and examination of methylation and age-related gene expression patterns. Further analyses were performed to explore the association between these key hub genes and colon adenocarcinoma (COAD). We identified four key hub genes-lipocalin-2 (), matrix metalloproteinase-9 (), S100 calcium-binding protein A9 (), and olfactomedin-4 ()-significantly up-regulated in UC, with showing epigenetic regulation and age-dependent expression patterns. Additionally, S100A9 was strongly associated with poor prognosis in COAD, displaying hypo-methylation and elevated expression, especially in myeloid cell types, and links to altered immune and molecular subtypes. Our findings confirmed the hypo-methylation-driven up-regulation of , , and in UC, suggesting their potential as blood-based diagnostic biomarkers. Notably, S100A9 has emerged as a promising biomarker for the early diagnosis of ulcerative colitis, particularly in pediatric and adolescent patients with UC. Moreover, S100A9 holds potential as a precision target to prevent progression from UC to CAC.

摘要

溃疡性结肠炎(UC)是一种慢性炎症性肠病,其特征为黏膜炎症和使人衰弱的症状,这些症状会严重损害生活质量。UC在年轻人群中尤为普遍,由于症状不具特异性以及有进展为结肠炎相关癌症(CAC)的可能性,早期诊断仍然具有挑战性。对包含全血样本的GSE177044数据集进行了分析,以识别差异表达基因、进行基因注释、分析关键信号通路,并使用蛋白质-蛋白质相互作用网络检测UC中的关键枢纽基因。使用由结肠样本组成的多个UC数据集进行验证以及甲基化和年龄相关基因表达模式的检查。进行了进一步分析以探索这些关键枢纽基因与结肠腺癌(COAD)之间的关联。我们鉴定出四个关键枢纽基因——脂钙蛋白-2()、基质金属蛋白酶-9()、S100钙结合蛋白A9()和嗅觉介质-4()——在UC中显著上调,其中 表现出表观遗传调控和年龄依赖性表达模式。此外,S100A9与COAD的不良预后密切相关,表现为低甲基化和表达升高,尤其是在髓样细胞类型中,并且与免疫和分子亚型的改变有关。我们的研究结果证实了UC中 、 和 由低甲基化驱动的上调,表明它们作为基于血液的诊断生物标志物的潜力。值得注意的是,S100A9已成为溃疡性结肠炎早期诊断的一个有前景的生物标志物,特别是在儿科和青少年UC患者中。此外,S100A9作为预防UC进展为CAC的精准靶点具有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/67095ac169ef/ijms-26-05693-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/e90ce5298c34/ijms-26-05693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/645d4c2e2a24/ijms-26-05693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/fc44c973f8c8/ijms-26-05693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/e8d59ef7a2e4/ijms-26-05693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/c20a42a62714/ijms-26-05693-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/67095ac169ef/ijms-26-05693-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/e90ce5298c34/ijms-26-05693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/645d4c2e2a24/ijms-26-05693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/fc44c973f8c8/ijms-26-05693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/e8d59ef7a2e4/ijms-26-05693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/c20a42a62714/ijms-26-05693-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b43/12192605/67095ac169ef/ijms-26-05693-g006.jpg

相似文献

1
Exploring the Clinical Implication of S100A9 in Ulcerative Colitis and Its Progression to Cancer: A Journey from Inflammation to Cancer.探索S100A9在溃疡性结肠炎及其癌变过程中的临床意义:从炎症到癌症的历程
Int J Mol Sci. 2025 Jun 13;26(12):5693. doi: 10.3390/ijms26125693.
2
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
3
KunMingShanHaiTang formula reprograms macrophage metabolism and promotes M2 polarization via the HIF-1α pathway to alleviate ulcerative colitis symptoms in a rat model.昆明山海丹方通过HIF-1α途径重编程巨噬细胞代谢并促进M2极化,以减轻大鼠模型中的溃疡性结肠炎症状。
J Bioenerg Biomembr. 2025 Apr 2. doi: 10.1007/s10863-025-10056-z.
4
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
5
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.普通肝素或低分子量肝素用于诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2008 Apr 16(2):CD006774. doi: 10.1002/14651858.CD006774.pub2.
6
Homoplantaginin inhibits the progression of ulcerative colitis in mice by regulating the MMP9-RLN2 signaling axis.高车前素通过调节MMP9-RLN2信号轴抑制小鼠溃疡性结肠炎的进展。
Front Med (Lausanne). 2025 Jun 2;12:1582066. doi: 10.3389/fmed.2025.1582066. eCollection 2025.
7
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
8
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.普通肝素或低分子量肝素用于诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2010 Oct 6(10):CD006774. doi: 10.1002/14651858.CD006774.pub3.
9
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
10
Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM.全面的泛癌分析揭示NTN1作为一种免疫浸润风险因素及其在皮肤黑色素瘤中的潜在预后价值。
Sci Rep. 2025 Jan 25;15(1):3223. doi: 10.1038/s41598-025-85444-x.

本文引用的文献

1
Characteristics of Pediatric Ulcerative Colitis at Diagnosis in Korea: Results From a Multicenter, Registry-Based, Inception Cohort Study.韩国儿童溃疡性结肠炎诊断时的特征:一项基于多中心注册的起始队列研究结果
J Korean Med Sci. 2024 Dec 23;39(49):e303. doi: 10.3346/jkms.2024.39.e303.
2
Unveiling Biomarkers in Head and Neck Squamous Cell Carcinoma through Bioinformatics: The Role of and .通过生物信息学揭示头颈部鳞状细胞癌中的生物标志物: 和 的作用。
Int J Mol Sci. 2024 Nov 10;25(22):12062. doi: 10.3390/ijms252212062.
3
Impact of potential biomarkers, SNRPE, COX7C, and RPS27, on idiopathic Parkinson's disease.
潜在生物标志物SNRPE、COX7C和RPS27对特发性帕金森病的影响。
Genes Genomics. 2025 Jan;47(1):47-57. doi: 10.1007/s13258-024-01591-x. Epub 2024 Oct 28.
4
Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study.活动期和静止期溃疡性结肠炎患者腹痛相关因素:一项多队列研究
Aliment Pharmacol Ther. 2025 Jan;61(2):268-277. doi: 10.1111/apt.18344. Epub 2024 Oct 23.
5
Ulcerative colitis: molecular insights and intervention therapy.溃疡性结肠炎:分子见解与干预治疗。
Mol Biomed. 2024 Oct 10;5(1):42. doi: 10.1186/s43556-024-00207-w.
6
Interferon regulatory factor 7 alleviates the experimental colitis through enhancing IL-28A-mediated intestinal epithelial integrity.干扰素调节因子 7 通过增强 IL-28A 介导的肠道上皮完整性来缓解实验性结肠炎。
J Transl Med. 2024 Oct 6;22(1):905. doi: 10.1186/s12967-024-05673-y.
7
Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021.炎症性肠病的全球、区域和国家负担,1990-2021:来自 2021 年全球疾病负担的见解。
Int J Colorectal Dis. 2024 Sep 7;39(1):139. doi: 10.1007/s00384-024-04711-x.
8
Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis.阐明 S100A9 的泛肿瘤全景:整合生物信息学和孟德尔随机分析的预后和治疗推论。
Sci Rep. 2024 Aug 17;14(1):19071. doi: 10.1038/s41598-024-70223-x.
9
Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis.预测用于人类溃疡性结肠炎早期诊断和动态严重程度监测的新型生物标志物。
Front Genet. 2024 Jul 31;15:1429482. doi: 10.3389/fgene.2024.1429482. eCollection 2024.
10
Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations.溃疡性结肠炎管理的自然方法:临床前和临床研究证据
Nat Prod Bioprospect. 2024 Jul 30;14(1):42. doi: 10.1007/s13659-024-00463-x.